Bank Julius Baer & Co’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-278
| Closed | -$17K | – | 607 |
|
|
2021
Q4 | $17K | Hold |
278
| – | – | ﹤0.01% | 752 |
|
|
2021
Q3 | $14K | Sell |
278
-3
| -1% | -$151 | ﹤0.01% | 765 |
|
|
2021
Q2 | $16K | Buy |
281
+3
| +1% | +$171 | ﹤0.01% | 766 |
|
|
2021
Q1 | $16K | Sell |
278
-2
| -0.7% | -$115 | ﹤0.01% | 760 |
|
|
2020
Q4 | $19K | Sell |
280
-131
| -32% | -$8.89K | ﹤0.01% | 749 |
|
|
2020
Q3 | $104K | Buy |
411
+1
| +0.2% | +$253 | ﹤0.01% | 562 |
|
|
2020
Q2 | $69K | Buy |
410
+134
| +49% | +$22.6K | ﹤0.01% | 543 |
|
|
2020
Q1 | $19K | Buy |
+276
| New | +$19K | ﹤0.01% | 583 |
|